Perceptive Advisors LLC Icosavax, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $2.93 Million - $8.74 Million	-949,259 Reduced 91.03%	93,591 $296,000
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $1.92 Million - $3.47 Million	-336,287 Reduced 24.38%	1,042,850 $5.98 Million
Q1 2022 May 16, 2022	SELL	$4.41 - $22.5 $2.33 Million - $11.9 Million	-527,411 Reduced 27.66%	1,379,137 $9.71 Million
Q4 2021 Feb 14, 2022	SELL	$21.07 - $34.98 $337,141 - $559,714	-16,001 Reduced 0.83%	1,906,548 $43.6 Million
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $47.8 Million - $77.4 Million	1,922,549 New	1,922,549 $56.9 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.